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Maternal euthyroidism during pregnancy is crucial for normal development and, in particular, neurodevelopment of the foetus.
Up to 3.5 percent of pregnant women suﬀer from hypothyroidism. Industrial use of various chemicals—endocrine disrupting
chemicals (EDCs)—has been shown to cause almost constant exposure of humans with possible harmful inﬂuence on health
and hormone regulation. EDCs may aﬀect thyroid hormone homeostasis by diﬀerent mechanisms, and though the eﬀect of each
chemical seems scarce, the added eﬀects may cause inappropriate consequences on, for example, foetal neurodevelopment. This
paper focuses on thyroid hormone inﬂuence on foetal development in relation to the chemicals suspected of thyroid disrupting
propertieswithpossibleinteractionswithmaternalthyroidhomeostasis.Knowledgeoftheeﬀectsisexpectedtoimpactthegeneral
debate on the use of these chemicals. However, more studies are needed to elucidate the issue, since human studies are scarce.
1.Introduction
Maintaining maternal euthyroidism during pregnancy is im-
portant for growth and development, in particular neurode-
velopmentofthefoetus.Evensubtlechangesinthyroidfunc-
tion of the pregnant woman can cause detrimental eﬀects
for the foetus [1–5]. In the ﬁrst trimester, the foetus relies
solely on the thyroid hormones thyroxine (T4) and tri-
iodothyronine (T3) and iodine from the mother. Later in
pregnancy and during lactation, maternal thyroid hormones
still contribute signiﬁcantly tofoetal thyroidhomeostasis [6–
8]. Worldwide, both overt and subclinical hypothyroidism
are frequent among fertile women [9–14]. Prior maternal
thyroid diseases as well as iodine and selenium deﬁciencies
are known risk factors for hypothyroidism.
Abundant industrial and household use of various
chemicals—calledendocrinedisruptingchemicals(EDCs)—
expose humans with potential harmful inﬂuences on health
and hormone regulation. As recently reviewed, several of
theseEDCshavebeenfoundtohavethyroiddisruptingprop-
erties as well [15–17]. Probably each chemical has limited
thyroid disruptive eﬀects at environmental exposure doses.
However, the combined inﬂuence of several chemicals
through diﬀerent pathways of thyroid hormone synthesis
and action may have signiﬁcant impact on both maternal
and foetal thyroid function [18, 19] and, thus, a potential to
compromise foetal development and maturation.
This paper will focus on the inﬂuence of thyroid hor-
mones on foetal development in relation to the chemicals
suspected to have thyroid disrupting properties. Knowledge
on these eﬀects is expected to impact international debate on
the general use of these chemicals.
2.MaternalandFoetalThyroidStatus
duringPregnancy
The main task of the thyroid gland is to generate the neces-
saryquantityofthyroidhormonetomeetthedemandsofthe
organism. The mechanisms involved in thyroid homeostasis
are shown in Figure 1.E a c hs t e po ft h y r o i dh o r m o n em e -
tabolism is crucial for normal function. Maternal thyroid2 Journal of Thyroid Research
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Figure 1: The complex mechanisms of regulation of thyroid hormone homeostasis and the possible mechanism of action of the thyroid
disruptingchemicals.Thethyroidandthethyroidhormones,tri-iodothyronine(T3)andthyroxine(T4),participatewiththehypothalamus,
secreting thyrotropin releasing hormone (TRH), and pituitary, secreting thyrotropin (TSH) in a classical feedback controlled loop. Iodide is
transportedintothecellbythesodium-iodinesymporter(NIS)andoxidizedbythyroidperoxidase(TPO).TPOalsocatalyzestheiodination
of thyrosine residues on thyroglobulin (Tg). All processes in the cell are stimulated by binding of TSH to the TSH receptor (TSH-R). In the
circulation, thyroid hormones are bound to thyroxine-binding globulin (TBG), albumin and prealbumin, and in some cases transthyretin
(TTR).T4isdeiodinatedbydeiodinasesintheliverandtargettissues.Inthetargetcells,T3bindstonuclearthyroidhormonereceptor(TR),
and with the retinoid X receptor, it binds at speciﬁc sequences at the DNA string, forming the thyroid hormone response elements (TRE). In
the liver, thyroid hormones are metabolized by UDP-glucuronyl transferase (UDPGT), and ﬁnally, the metabolites are excreted in the urine.
(1) Inhibition of iodine uptake in the cells by inhibition of NIS: perchlorate, thiocyanate, nitrate, and phthalates. (2) TPO inhibition: NP and
isoﬂavones. (3) Inhibition of TSH-R: DDT and PCB. (4) Binding to transport proteins: PCB, phthalates, phenol, ﬂame retardants, and HCB.
(5) Cellular uptake of thyroid hormones: phthalates and chlordanes. (6) Binding to thyroid hormone receptor and aﬀecting gene expression:
PCB, phenols, ﬂame retardants, BPA and HCB. (7) Inhibition of deiodinases: Styrenes and UV-ﬁlters, (8) Activation of hepatic UDPGT:
dioxins and pesticides, (9) Inhibition of the hypothalamo-pituitary-thyroid axis: lead. (10) Excretion/clearance of thyroid hormones: PCB,
dioxin, phenols, ﬂame retardants, HCB, and BPA.
status is subject to substantial pregnancy-related physio-
logical changes. Importantly, maternal thyroid hormone is
metabolized by or crosses the placenta to reach the foetus
[20]. In the placenta, the inner ring placental deiodinase
inactivates most of the maternal T4 to reverse T3 (rT3),
securing a minimal but highly signiﬁcant supply of thyroid
hormones to the foetus [20, 21], which further demands an
increased thyroid hormone production by the mother.
The foetal thyroid function is established in the 11th
week after conception [6]. However, the production and
secretion of foetal thyroid hormones do not reach notable
levels until midgestation [6]. Even at term, up to 30% of
the foetal thyroid hormones are of maternal origin [22], and
during the remaining part of pregnancy and lactation, the
foetus and neonate are strongly dependent on the maternal
thyroid gland.
3. Inﬂuence of Maternal Thyroid Disease on
FoetalDevelopment
The estimated prevalence of overt and subclinical hypothy-
roidism in pregnancy is 0.5% and 3%, respectively. Thyroid
autoantibodies are found in 5%–15% of women of child-
bearing age [9–14]. The estimated high prevalence of thyroid
disease in pregnant women has spurred a debate of whether
screening of all pregnant women, instead of only targetedJournal of Thyroid Research 3
case-ﬁnding, should be advised. In recent studies, 50% to
80% of the pregnant women with possible hypothyroidism
would be missed if only high-risk cases were examined [23,
24], but screening of all pregnant women is not yet agreed
upon in international scientiﬁc associations [25].
At least 50% of the oﬀspring of women with free T4
(fT4) levels below the normal 10th percentile had delayed
neurobehavioral development [2, 3, 26]. Even mild-to-
moderate iodine deﬁciency during ﬁrst trimester caused an
intelligence quotient (IQ) 10–15 points below the normal
mean and 11 of 16 children born to mothers with low iodine
intake presented attention deﬁcit hyperactivity disorders
[27].Iodinedeﬁciencyisthemostfrequentcauseofmaternal
hypothyroxinaemia and a potentially preventable cause of
mental retardation in children.
4.EndocrineDisruptingChemicals and
the ThyroidGland
In recent years, numerous chemicals have been shown to
interfere at diﬀerent levels of thyroid hormone regulation
and function (Figure 1). Most chemicals have not yet been
suﬃciently evaluated in humans. Yet, a number of detrimen-
tal eﬀects on human thyroid function are suspected from a
variety of chemicals, and a review of available evidence on
this issue will be focused upon in the following.
4.1. Perchlorate. Perchlorate is a persistent ubiquitous chem-
icalusedworldwideinnitratefertilizers,ﬁreworks,roadﬂare,
matches, airbag inﬂation systems, and as oxidizers in solid
propellants for rockets and missiles. Perchlorate appears in
drinking water, milk, wine, beer, and lettuce, but also a nat-
ural perchlorate background of atmospheric origin exists
[28]. Perchlorate has previously been used in the treatment
of hyperthyroidism [29] due to its potent competitive inhi-
bition of thyroid iodine uptake through the sodium-iodine
symporter (NIS) [30]. However, the thyroid disrupting eﬀect
of perchlorate is dose dependent. Thus, occupational or
environmentalexposuresofperchloratehavebeenassociated
with a reduction in thyroid iodine uptake [31–33] but with-
out direct eﬀects on thyroid function or volume except
in a study of women with urinary iodine excretion below
100μg/L in whom TSH was increased and TT4 was found
reduced [34], and these ﬁndings are further supported by
ﬁndings of an interaction of perchlorate and thiocyanate
on thyroid status in smoking women with low iodine
intake [35]( Table 1). A study of euthyroid and hypothyroid
pregnant women from Cardiﬀ in Wales and Turin in Italy
found perchlorate in all urine samples and low iodine
excretion from all the pregnant women, but no correlation
was found between perchlorate levels and thyroid function
parameters [36]. Likewise, in pregnant women and their
neonates, perchlorate in drinking water did not inﬂuence
thyroid hormone levels [37, 38], and no correlations were
found between urinary perchlorate concentrations and fT4
or thyroid stimulating hormone (TSH), respectively, during
ﬁrst trimester in mildly hypothyroid women. Iodine is
secreted into breast milk through NIS, and one study found
that the highest concentrations of perchlorate in breast milk
were associated with lower iodine concentrations [39], while
others found no obvious correlations [40].
4.2. Thiocyanate and Nitrate. Thiocyanate and nitrate are
less potent inhibitors of NIS than perchlorate [30] but, ni-
trate may decrease iodine absorption from the intestine [47].
Thiocyanate is present in a number of vegetables such
as cabbage, broccoli, Brussels sprouts, rapeseed and mustard
seed, cassava, radishes, spinach and tomatoes but also in
milk. In many tropical countries, cassava as staple food
is a major ingredient in the daily food supply. In iodine-
deﬁcient regions, food with high concentrations of thio-
cyanate contributes signiﬁcantly to goitre development [48,
49]. However, in industrialized societies, the main source
of thiocyanate is cigarette smoke [48]. Although this has
well-known detrimental eﬀects on the thyroid function of
neonates and breastfed babies, it is beyond the scope of this
paper.
Nitrate is found in several food items either occurring
naturally, as in green leafy vegetables, or added as a preserva-
tiveincubedmeatsandotherfoodandisalsogeneratedfrom
the decomposition of organic materials. Inorganic nitrates
are used as fertilizers, which may contaminate drinking
water supplies, groundwater, and soil. Finally, the intestinal
ﬂora causes an endogenous formation of nitrate. Population
studies on nitrate exposure through drinking water have
found increased thyroid volume and slightly reduced thyroid
function [50], but the isolated eﬀect of nitrate has been
diﬃcult to assess due to concomitant iodine deﬁciency [51,
52]. But low levels of nitrate intake did not inﬂuence thyroid
volume in adults despite of previous iodine deﬁciency [53].
4.3. Polychlorinated Biphenyls (PCBs). PCBs are still in use
though several of them have been banned for decades in
manycountries.PCBsandtheirhydroxylatedmetabolitesare
biologically active, highly persistent compounds accumulat-
ing in lipid tissues, and structurally very close to T4 [54].
Many studies have been performed on the thyroid disturbing
eﬀects of PCBs, but results are conﬂicting (Table 2). PCBs
may interfere with thyroid hormone homeostasis in several
ways (Figure 1): by binding to transthyretin (TTR) [55],
by aﬀecting the expression of thyroid hormone-responsive
genes, and by antagonizing the complexes from the thyroid
hormone responsive elements (TRE) [56, 57]. Perinatal ex-
posure may be most important in humans. Negative corre-
lations have been demonstrated between PCBs in maternal
blood during pregnancy and maternal thyroid hormones,
and positive correlations have been described between PCBs
and TSH [58]. As thyroid hormones in humans are mainly
bound to thyroid hormone-binding globulin (TBG), the
reduction in total T4 (TT4) and total T3 (TT3) could be
explained by a reduced TBG level, whereas this would not
necessarily aﬀect free hormone levels [59]. In cord blood,
a positive correlation of PCB and TSH of the child and a
negative correlation with maternal TT3 and TT4 were found
[60]. PCBs in cord blood have generally not demonstrated
associations to T3 and T4 levels of the child [58, 61–65],4 Journal of Thyroid Research
Table 1: Thyroid-disrupting properties of perchlorate in human studies on pregnant women, neonates, infants, adolescents, and adults and
the eﬀect of perchlorate on iodine contents in breast milk.
Year Author N Subjects Eﬀect Reference
2005 Tellez et al. 185 Early pregnant women No eﬀect [38]
135 Late pregnant women No eﬀect
162 Newborns No eﬀect
2010 Pearce et al. 1641 Pregnant women No eﬀect [36]
2000 Brechner et al. 1542 Newborns ↑TSH [41]
2000 Li et al. 23000 Newborns No eﬀect [42]
2007 Amitai et al. 1156 Newborns No eﬀect [37]
2000 Crump et al. 9784 Newborns ↓TSH otherwise no eﬀect [43]
162 Schoolchildren No eﬀect
2006 Blount et al. 350 Iodine deﬁcient women ↓ TT4 ↑TSH [34]
697 Iodine suﬃcient women ↑TSH
Men No eﬀect
2000 Lawrence et al. 9 Healthy volunteers No eﬀect [33]
↓ thyroid radioiodine up-take
2002 Greer et al. 8 Healthy volunteers ↓ thyroid radioiodine up-take [32]
2006 Braverman et al. 13 Healthy volunteers No eﬀect [44]
1998 Gibbs et al. 119 Occupationally exposed No eﬀect [45]
1999 Lamm et al. 58 Occupationally exposed No eﬀect [46]
2005 Braverman et al. 29 Occupationally exposed ↓ thyroid radioiodine up-take [31]
2005 Kirk et al. 36 Lactating women ↓ Iodine in breast milk [39]
2007 Pearce et al. 57 Lactating women No eﬀect on iodine in breast milk [40]
N:number,TSH:thyrotropin,TT3:totaltri-iodothyronine,TT4:totalthyroxine,fT3:freeTri-iodothyronine,fT4:freethyroxine,andTBG:thyroidhormone-
binding globulin.
except in a recent study ﬁnding higher TSH and lower T4 in
infants of mothers with high levels of PCB in breast milk [66,
67]. Yet, not all studies found associations between infant
thyroid hormone levels and PCB exposure [63–65, 68], and
in a study of a prenatal boys exposed to high PCB levels, the
thyroidfunctionwascomparabletothatofthecontrolgroup
[69].
I ns e v e r a ls t u d i e so fh u m a n so fa l la g e sf r o mh i g h
PCB-exposed areas, blood PCB concentrations correlated
negatively to circulating thyroid hormone levels [76, 79, 80,
83]a n dp o s i t i v e l yt oT S H[ 74], while others could not ﬁnd
such associations [78, 81]. Increased thyroid volume has also
been found more often in a PCB-polluted area with the
largest volumes among subjects with the highest levels of
PCB [82].
4.4. Dioxin. Dioxins are highly toxic, lipophilic, widely used,
and persistent environmental pollutants from industrial
burning processes or production of herbicides, detectable
in samples from humans and wildlife populations though
banned for years in many countries. The most toxic pro-
totype is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and
the toxic equivalent of all other dioxins is measured against
this. In particular, the metabolites show a high degree of
structural similarity to T4 and are the most biologically
active. Dioxins have been found to decrease the level of
circulating thyroid hormones in rats [85–87], and mixtures
of dioxin-like compounds were even found to reduce levels
of T4 in an additive manner [88]. Given to pregnant rats,
a single dose of TCDD was transferred to the pups via
placenta and during lactation [89] and resulted in a dose-
dependent decrease of T4 and fT4 with a concomitant
increase in TSH [86, 87]. High exposure with TCDD of US
war veterans of the Vietnam war resulted in signiﬁcantly
increased TSH [90]. In children, no associations between
placental dioxins and thyroid hormones were found at the
age of 2 years, but after 5 years, T3 was signiﬁcantly higher in
the highly exposed individuals in utero [91]. But as recently
reviewed, so far, no clear and signiﬁcant correlation between
backgroundexposuretodioxinsandthyroidfunctionduring
development has been found [92].
4.5. Phthalates. Phthalates are widely used chemicals mainly
to improve the ﬂexibility of materials such as plastic and
have been widely used in medical products, food handling
and storage products, electrical devices, toys, and in non-
polyvinylchloride applications such as paints, lacquers, and
cosmetics. Phthalates can leach, migrate, or evaporate into
indoor air and atmosphere, foods, and liquids and have
become ubiquitous. Consequently, humans are constantly
exposed by oral, inhalation, and dermal routes [93]. Unfor-
tunately,certainvulnerablegroupsmaybemassivelyexposed
to phthalates,suchashospitalized neonates in whomurinary
excretion of phthalates was shown to correlate with exposureJournal of Thyroid Research 5
Table 2: Thyroid-disrupting properties of polychlorinated biphenyls in human studies on pregnant women, neonates, infants, adolescents,
and adults.
Year Author N Subjects Eﬀect Reference
1994 Koopman-Esseboom et al. 105 Pregnant women ↓ TT3 ↓ TT4 [62]
105 Infants ↑TSH at 2 weeks and 3 months
2005 Takser et al. 101 Pregnant women ↓ TT3 ↑TSH [58]
92 Cord blood No eﬀect
2008 Wilhelm et al. 165 Pregnant women No eﬀect [65]
127 Cord blood No eﬀect
2009 Alvarez-Pedrerol et al. 1090 Pregnant women ↓TT3↑fT4 [70]
2009 Dallaire et al. 120 Pregnant women ↑T3 [71]
95 Cord blood ↓TBG↓ fT4
130 Infants, 7 months old No eﬀect
2000 Longnecker et al. 160 Cord blood No eﬀect [63]
2005 Wang et al. 118 Cord blood ↓T3↓T4 [72]
2008 Dallaire et al. 670 Cord blood ↓TBG [68]
2008 Herbstman et al. 289 Cord blood, ↓TT4↓fT4 [67]
265 Neonatal blood spot∗∗ ↓TT4
2007 Chevrier et al. 285 Newborns ↑TSH [66]
2001 Matsuura et al. 337 Breastfed infants∗ No eﬀect [64]
2003 Ribas-Fito et al. 98 Infants Trend toward ↑TSH [61]
2010 Darnerud et al. 150 Infants ↓ TT3 [73]
1999 Osius et al. 320 Children ↓ fT3 ↑TSH [74]
2000 Steuerwald et al. 182 Children No eﬀect [60]
2008 Alvarez-Pedrerol. 259 Children ↓TT3↓fT4 [75]
2005 Hsu et al. 60 Boys No eﬀect [69]
2008 Schell et al. 232 Adolescents ↓ fT4↑TSH [76]
2001 Sala et al. 192 Adults Trend toward ↑TSH [77]
2001 Hagmar et al. 110 Adult men No eﬀect [78]
2001 Hagmar et al. 182 Adult women ↓ TT3 [79]
2001 Persky et al. 229 Adults Female: ↓T4,FTI. Men ↓T3-uptake [80]
2003 Bloom et al. 66 Adults No eﬀect [81]
2003 Langer et al. 101 Adults ↑thyroid volume [82]
2004 Schell et al. 115 Adults ↓ fT4↓ T4 ↑TSH
2007 Tyruk et al. 2445 Adults ↓TT4, in older persons↑TSH [83]
2008 Abdelouahab et al. 211 Adults Female ↓T3; men ↓T4 ↑TSH [84]
2009 Dallaire et al. 623 Adults ↓ TT3, ↓TBG [59]
PCBs were measured in blood unless otherwise stated. ∗PCBs measured in breast milk. ∗∗neonatal blood spot at day 18 postpartum. N:n u m b e r ,T S H :
thyrotropin,TT3:totaltri-iodothyronine,TT4:totalthyroxine,fT3freeTri-iodothyronine,fT4:freethyroxine,FTI:freeT4index,andTBG:thyroidhormone-
binding globulin.
to medical devices [94]. However, a followup of adolescents
exposed to high concentrations of phthalates in the neonatal
period showed normal thyroid hormones [95]. On the other
hand, men recruited from a fertility clinic [96] and pregnant
women [97] demonstrated a negative association between
phthalates and fT4 and T3, respectively.
We studied 845 children aged 4–9 years with determina-
tion of urinary concentrations of 12 phthalate metabolites
and serum levels of TSH, thyroid hormones, and insulin-
like growth factor-I (IGF-I) [98]. Our study showed a neg-
ative association between urinary phthalate concentrations
and thyroid hormones, IGF-I and growth of the children,
respectively. Although our study was not designed to reveal
the mechanism of action, the overall coherent negative as-
sociations may suggest causative negative roles of phthalate
exposures for child health.
4.6. Triclosan and Bisphenol A. The exact thyroid disturbing
mechanisms of these chemicals are not known, but triclosan,
and bisphenol A (BPA) share structural similarities with
thyroid hormones and may bind to and interact with the
thyroid hormone receptor (TR). Phenols bind competitively
to TTR, [99, 100] and act as a T3 antagonist [101, 102].
BPA is used to manufacture polycarbonate and several
hardplasticproductssuchascompactdiscs,foodcanlinings,
adhesives, powder paints, dental sealants, and clear plastic6 Journal of Thyroid Research
bottles which means that humans are ubiquitously exposed
to BPA [103, 104]. BPA is rapidly glucuronidated in humans
and rodents.
Phenols were found to bind competitively to TTR, possi-
bly with a very strong binding aﬃnity [99, 100], but a recent
study found that the concentrations of BPA usually found
in humans is probably not high enough to interfere with
T4 transport [105]. Finally, T3-mediated gene activation
through TRα1a n dT R β was dose-dependently suppressed
by, BPA and the expression of T3- suppressed genes was
up-regulated by BPA [101, 102]. In pregnant rats, BPA was
associated with a signiﬁcant increase of TT4 in the pups 15
days postpartum [106].
Triclosan in an antibacterial and antifungal agent used in
productsforpersonalhygieneandhouseholdcleaningagents
but also in plastics and fabrics. Though found in human
urine [107] and breast milk [108], so far, no epidemiological
studies have been published on the inﬂuence of triclosan on
thyroid hormone homeostasis. A small intervention study
[109] could not demonstrate changes in CYP3A4-activity or
peripheral thyroid hormone levels after triclosan exposure
through toothpaste. However, in vitro studies suggest that
higher exposure levels may activate human pregnane x
receptor, which upregulates the activity of CYP3A4 [110].
In rats, gestational exposure to triclosan lowered T4 in the
pregnant animal and transitorily in the pups at postnatal day
4[ 111, 112].
4.7. Isoﬂavones. Isoﬂavones, naturally occurring phytoestro-
gens, are mainly found in soy and grain products [113].
Isoﬂavones inhibit thyroid peroxidase (TPO) function and
thereby thyroid hormone production [114]. Iodine insuﬃ-
cient children fed on soy products risk development of goitre
and hypothyroidism [115]. As reviewed by Messina and
Redmond several studies have been performed in humans
to explore the thyroid disrupting eﬀect of isoﬂavones, but
only one study from Japan of healthy volunteers fed for 1–
3 months with soy beans reported increased TSH though
within the normal reference interval and increased thyroid
volume. But other studies could not reveal such relationships
[116].
4.8. Brominated Flame Retardants. Flame retardants consti-
tute a group of chemicals such as tetrabromobisphenol A
(TBBPA), a halogenated derivative of BPA and polybromi-
nated biphenyls. These chemicals are found in diﬀerent
products such as plastic paints and synthetic textiles and are
oftenusedinelectricaldevicessuchastelevisions,computers,
copying machines, video displays, and laser printers. These
chemicals are structurally more similar to T4 than PCBs and
bind competitively to TTR [99]. In general, ﬂame retardants
are found to reduce thyroid hormone levels. A recently
published study of pregnant women showed a negative asso-
ciation between serum levels of brominated ﬂame retardants
and TSH [117]. A newer study of recreational ﬁsh consumers
reported a negative association between concentrations of
some congeners in serum and serum levels of T3 and TSH
andapositiverelationshipwithT4[118].Thiswasconﬁrmed
by others [78]b u tn o ta l l[ 119], and in a smaller study of
12 mother-infant pairs, maternal brominated ﬂame retar-
dants levels were not signiﬁcantly correlated to thyroid
hormone levels in cord blood [120].
4.9. Pesticides. Pesticides constitute a large and very inho-
mogeneous group of chemicals, which diﬀer signiﬁcantly
in their chemical and physical properties and, thus, their
ability to be either detoxiﬁed in vivo or to bioaccumulate
in lipid-rich tissue. It is beyond the scope of the paper
to give a comprehensive overview about potential thyroid
disrupting eﬀects. Many of the organochlorine pesticides are
persistent with long environmental half-lives, and therefore,
humans are continuously exposed though many pesticides
have been banned for years in many countries while still
in use in others. Dichlorodiphenyltrichloroethane (DDT),
hexachlorobenzene (HCB), and nonylphenol (NP) are
among the most examined. Metabolites of HCB are used
as a biocide and wood preservative in the timber industry
and as antifungal agent in the leather industry. NP is an
industrialadditiveusedindetergents,plastics,andpesticides.
In humans, an enlarged thyroid was found after accidental
exposure to HCB [121], and studies have found negative
associations between HCB and T4 [77, 81]o rT 3[ 58]b u t
not TSH or free thyroid hormone levels [77]. In newborns,
pentachlorphenol(PCP)incordbloodbutnotHCB[58]was
negativelycorrelatedtoT3,fT4andTBG[122],andthusmay
potentially impair neurodevelopment. Also, other pesticides
seem to posses thyroid disrupting properties [123–127].
4.10. Others. Ultraviolet (UV) ﬁlters also called sunscreens,
thatis,benzophenone,4-methylbenzylidenecamphorand3-
benzylidene camphor, comprise a group of chemicals used to
absorb and dissipate UV irradiation in cosmetic products,
not only sun lotions, to enhance product longevity and
quality.Sofar,onlyanimalandinvitrostudieshaveindicated
that UV ﬁlters may disrupt thyroid hormone homeostasis.
Parabens are commonly used as preservatives in food,
cosmetics and pharmaceutical products. In vitro methyl-
paraben dose-dependently inhibited iodine organiﬁcation
and thus seemed to have a weak intrinsic antithyroid eﬀect
[128], but human studies are lacking.
The industrial use of perﬂuorinated chemicals (PFC)
is increasing in products such as stain- and oil-resistant
coatings for example, food packaging for fast food, as well
as in ﬂoor polishes and insecticide formulations. PFCs are
extremely persistent in the environment. Women with high
levels of PFCs were treated more often for thyroid disease
than controls [129], and in employees from a PFC factory,
PFCs displayed a negative association to fT4 [130].
Styrene is an industrial chemical widely used in the
production of plastics, resins, and polyesters. Humans are
exposed by low-level contamination in food items, but the
exposure is most abundant through inhalation of tobacco
smoke, automobile exhaust, and vapors from building
materials [131]. Occupational styrene exposure resulted in
thyroid disrupting eﬀects: there was a positive correlationJournal of Thyroid Research 7
between exposure time and thyroid volume and a posi-
tive correlation between urinary concentrations of styrene
metabolites and f T4 or fT4/fT3 ratios without a correlation
to TSH. This indicated an inhibition of the conversion of T4
to T3 [132].
Exposure to lead is typically from cigarette smoke or
gasoline, but also workers in the mining, smelting, re-
ﬁning, battery manufacturing, soldering, electrical wiring,
and ceramic glazing industries are at risk of occupational
exposure. Lead may cause a toxic eﬀect on the central part of
the hypothalamic-pituitary-thyroid axis [133, 134], but the
mechanism is not yet known and eﬀects on the selenium
metabolism is also possible. In lead-exposed children, an
impairedreleaseofTSHhasbeenreported[135],butanother
study found unchanged T4 levels after lead exposure [136].
Studies in occupational lead exposed workers indicates
induction of secondary hypothyroidism; one study found
low T4 and fT4 and inappropriately normal TSH [137]a n d
in auto repair workers, a negative correlation between blood
lead levels and fT4 was found, but TSH, T3, and thyroid
volume were comparable to unexposed controls [133]. In
another group of petrol pump workers or mechanics, TSH
was increased compared to the unexposed controls, and T3
declined by longer exposure, but T4 levels were unchanged
[134]. These ﬁndings are in contrast to the evaluation of
subacute and cumulative eﬀects in lead smelter workers,
where no thyroidal eﬀects were shown [138].
Lithium is widely used in the treatment of bipolar men-
tal disorders and has known inﬂuences on thyroid function
[139], and lithium is used in the manufacturing of button
and rechargeable batteries, ceramics, and glass. Recently,
lithium has been found in ground and drinking water in
Argentina, where the urine lithium concentration corre-
spondedtoadailylithiumintakeof2–30mg[140].Exposure
to lithium in drinking water and other sources seem to
suppress thyroid function as urinary lithium was found to
correlate negatively with T4 and positively with TSH [141].
5. Discussion
Asdiscussedabove,severalgroupsofEDCsmayhavethyroid
disrupting potential, but only perchlorate and PCBs have
been studied in more detail in humans. Perchlorate reduced
expectedly thyroid iodine uptake, but so far, no signiﬁcant
eﬀects on circulating thyroid hormones have been found
after exposure to environmental levels of either perchlorate,
thiocyanate, or nitrite. Most of the other chemicals have still
only been studied in animal models, sporadically, in high
doses in volunteers or after occupational or accidental expo-
sure, and results are conﬂicting. However, all the mentioned
chemicals can theoretically have thyroid disrupting proper-
ties and consequently further studies are needed to clarify
the mechanisms and the general consequences of constant
environmental exposure to lower doses. Although thyroid
disruptingpropertieswerenotdocumentedforallchemicals,
especially vulnerable groups like pregnant women, foetuses
and children of all ages may be more sensitive because of
pregnancy- and growth-related added stress on the thyroid
gland, in particular for people living in iodine insuﬃcient
areas. Most human studies are performed in groups like
healthy volunteers, occupationally exposed individuals, or
persons living in certain areas and do not include all thyroid
relevant factors as life style, preexisting thyroid disease, age
groups, or exposure to other EDCs. However, exposure
during the foetal and neonatal period is of much concern, as
it is a very vulnerable point in central nervous system devel-
opment, especially in preterm children. Only few studies of
the chemicals in question have addressed the issue of health
eﬀects on the oﬀspring of exposed subjects. Yet, many of the
potential thyroid disrupting chemicals accumulate both in
nature and in exposed individuals and may have a negative
inﬂuence on maternal thyroid function during pregnancy
with consequent risk of impaired neurodevelopment of the
foetus. While signiﬁcant exposure to all these chemicals are
suspected to aﬀect human thyroid homeostasis, the eﬀects
of environmental exposure still remain to be conﬁrmed in
humans and, in particular, in vulnerable groups.
Epidemiological studies have reported that pre- and
perinatal exposure to PCBs is associated with poorer neu-
rodevelopmentinneonates,toddlersandschool-agechildren
[142–147]. The inﬂuence of PCBs on thyroid function has
been suggested as a reasonable explanation for the results
although this was not evaluated in detail. PCB correlated
negatively to fT4 in pregnant women [148], and therefore,
even exposure at background levels could possible disturb
foetal development.
The subjects in human epidemiological studies have
always been exposed to many diﬀerent compounds through
diﬀerent time periods, and it is, therefore, diﬃcult to isolate
speciﬁc eﬀects of chemicals and their metabolites on func-
tions of the human organism, which is an obvious caveat in
concluding from such studies [59].
Some studies have been performed in people more in-
tensively exposed due to either occupation, residency in/near
contaminated areas [74, 90, 149, 150], accidents [151], or
ﬁsh consumption [78, 79, 152, 153], but other studies have
focused on general population exposures [58, 83, 96]. There
may, thus, be several reasons for the divergence in ﬁndings.
One explanation could be current low exposure after reduc-
tion of allowed limits and, therefore, current unmeasurable
levels of a chemical that once was present and exerted
an eﬀect. Conﬂicting results may also reﬂect that ﬁndings
depend on the choice of biomarkers, detection methods of
the examined EDCs, and sample material, for example, in
maternal blood, breast milk, cord blood, or child blood.
Furthermore the sex of the foetus, comorbidities, and med-
ication as well as a possible inﬂuence from combined eﬀects
of other EDCs may inﬂuence study outcomes [72]. Even in
adult populations, there are probably both age and gender
diﬀerences in responses in an adult population [83].
Given that most of the mentioned chemicals have subtle
inﬂuences on the thyroid axis, in many cases within the nor-
mal reference interval, the question is whether or not such
subtle changes in, for example, maternal thyroid function
caneventuallycompromisefoetalneurologicaldevelopment.
The relationship between T4 and TSH is very unique to each8 Journal of Thyroid Research
human [154], and the variations within each person are
much smaller than the variation within a population [155,
156], which is also the case during pregnancy [157, 158].
Comparison with more or less well-deﬁned population-
based reference ranges is probably quite irrelevant consid-
ering the discrepancy between these large ranges compared
to the much narrower intraindividual variations in thyroid
hormone levels [155, 156]. In addition, no ﬁrst-trimester-
speciﬁc reference ranges for fT4 analog assays currently exist,
available commercial analog fT4 assays are unreliable in
pregnant women, and fT4 levels are often over- or under-
estimated. In these cases, TT4 and free thyroid hormones
indexes are more reliable [159]. Consequently, minor, yet
real,changesinthyroidhormonelevelsduetoEDCexposure
in small human studies may easily be camouﬂaged by the
broad interindividual variation. As human exposure is life-
long, starting during pregnancy and cumulative for persis-
tent chemicals, it is not possible to design human studies
evaluating thyroid function within an individual before and
after exposure. Even small intervention studies, like the
study with triclosan [109], are performed on a preexisting
backgroundofchemicalexposure tomany othercompounds
simultaneously.
Despite this individuality of the thyroid function vari-
ables, the levels of TSH and thyroid hormones vary greatly
during the early stages of life. TSH increases dramatically
immediately after birth peaking at 30 minutes, followed by
an increase in T4 and T3, where after all hormone levels de-
crease. Thyroid hormones measured in newborns may be
aﬀected by intrapartum stress [67] and even by use of iodine
containing antiseptics [160]. Thus, estimation of any inﬂu-
ence of thyroid disrupting chemicals on TSH and thyroid
hormones during pregnancy, neonatal period, or early child-
hood should, therefore, allow for exact age as a critical con-
founder.
A possible inﬂuence of thyroid hormone-induced me-
tabolism and elimination processes of EDCs, such as detox-
iﬁcation in the liver and kidneys, has not been extensively
investigated, and further studies should be performed. Other
confounding factors in interpretation of the many results
include population-speciﬁc level of selenium and iodine,
since deﬁciency of these two substances may render the
thyroid system more prone to be aﬀected by EDCs. In
addition,exposuretoEDCsmaycauseonlytransientchanges
inthyroidhormonelevels,whichcannotbetracedafterwards
but, nevertheless, may leave permanent eﬀects on the central
nervoussystemifoccurringduringadevelopmentallycritical
phase. Furthermore, measurement of peripheral thyroid
hormone concentrations may not reﬂect a chemical eﬀect on
the full thyroid homeostasis (Figure 1). As outlined in this
paper, various chemicals may have diﬀerent and antagonistic
or synergistic eﬀects on the thyroid axis. Such eﬀects have
also been found in studies of chemicals disrupting reproduc-
tion [18, 19].
Finally, it is not possible in association studies to distin-
guish whether EDCs could act by direct toxic eﬀects or by in-
direct mechanisms via disrupting the thyroid function. More
mechanistic studies are, therefore, warranted in the future.
6. Conclusions
Theinﬂuenceofenvironmentalthyroiddisruptingchemicals
on maternal thyroid function and consequently on foetal
developmentinhumansisstilldiﬃculttoestimateforseveral
reasons. However, for some of the chemicals, in particular
perchlorate and PCBs, evidence is emerging that thyroid
function is indeed aﬀected by their exposure, and they there-
fore potentially possess a damaging eﬀect on foetal devel-
opment. However, many individual factors including the
narrowindividualsetpointforthyroidfunction,interactions
with other environmental factors such as exposure to sev-
eral EDCs, and deﬁciency of iodine and/or selenium may
interfere with study results and thereby complicate con-
clusions. Furthermore, it is still not clear which speciﬁc
cognitive functions in childhood, and consequently which
methods of testing, would be the most representative when
evaluating permanent eﬀects of thyroid dysfunction during
development. Further research in this particular ﬁeld is
necessary to ensure optimal health, growth and development
of the foetus, but also for subsequent general thyroid health
in children and adults. So, while most available evidence
indicates detrimental eﬀects of many EDCs on human thy-
roid function, thereby potentially aﬀecting pregnant women
and consequently foetal development, astonishingly few
studies can substantiate this suspicion. Since this may appear
to be extremely important for foetal neurodevelopment, re-
searchers in the ﬁeld should be strongly encouraged to con-
tinue the eﬀorts to elucidate the mechanisms in order to
be able to prevent damage. This may be so much more
important since both populations in iodine deﬁcient areas
but also in iodine suﬃcient areas, with high prevalence of
autoimmune hypothyroidism in women of the childbearing
age,haveanincreasedsusceptibilitytothethyroiddisrupting
properties of EDCs. The complexity of the ﬁeld and the
scarcity of current publications should spur researchers
to perform large-scale studies including all relevant con-
founders, thus hopefully allowing for evidence-based regu-
lations and recommendations.
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